These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9013377)

  • 1. Physical aspects of dexibuprofen and racemic ibuprofen.
    Leising G; Resel R; Stelzer F; Tasch S; Lanziner A; Hantich G
    J Clin Pharmacol; 1996 Dec; 36(12 Suppl):3S-6S. PubMed ID: 9013377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preliminary toxicokinetic study with different crystal forms of S (+)-ibuprofen (dexibuprofen) and R,S-ibuprofen in rats.
    Walser S; Hruby R; Hesse E; Heinzl H; Mascher H
    Arzneimittelforschung; 1997 Jun; 47(6):750-4. PubMed ID: 9239454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formulation of a extended release tablet containing dexibuprofen.
    Yi HG; Chi MH; Kim YI; Woo JS; Park ES
    Arch Pharm Res; 2008 Dec; 31(12):1637-43. PubMed ID: 19099235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Similarity in structures of racemic and enantiomeric ibuprofen sodium dihydrates.
    Zhang Y; Grant DJ
    Acta Crystallogr C; 2005 Sep; 61(Pt 9):m435-8. PubMed ID: 16143769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial salt screening procedures for manufacturing ibuprofen.
    Lee T; Wang YW
    Drug Dev Ind Pharm; 2009 May; 35(5):555-67. PubMed ID: 19005918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of physicochemical properties on the in vitro skin permeation of the enantiomers, racemate, and eutectics of ibuprofen for enhanced transdermal drug delivery.
    Yuan X; Capomacchia AC
    J Pharm Sci; 2013 Jun; 102(6):1957-1969. PubMed ID: 23589422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical stability of solid dispersions of enantiomeric or racemic ibuprofen in stearic acid.
    Corvis Y; Négrier P; Espeau P
    J Pharm Sci; 2011 Dec; 100(12):5235-43. PubMed ID: 21905027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resolution of enantiomers of ibuprofen by liquid chromatography: a review.
    Bhushan R; Martens J
    Biomed Chromatogr; 1998; 12(6):309-16. PubMed ID: 9861488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the efficacy and dose-response relationship of dexibuprofen (S(+)-ibuprofen) in patients with osteoarthritis of the hip and comparison with racemic ibuprofen using the WOMAC osteoarthritis index.
    Singer F; Mayrhofer F; Klein G; Hawel R; Kollenz CJ
    Int J Clin Pharmacol Ther; 2000 Jan; 38(1):15-24. PubMed ID: 10667832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An examination of the thermodynamics of fusion, vaporization, and sublimation of ibuprofen and naproxen by correlation gas chromatography.
    Maxwell R; Chickos J
    J Pharm Sci; 2012 Feb; 101(2):805-14. PubMed ID: 22081306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
    Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
    Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of ibuprofen solubility in wax: a comparison of microscopic, thermal and release rate techniques.
    Oladiran GS; Batchelor HK
    Eur J Pharm Biopharm; 2007 Aug; 67(1):106-11. PubMed ID: 17321730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188.
    Newa M; Bhandari KH; Li DX; Kwon TH; Kim JA; Yoo BK; Woo JS; Lyoo WS; Yong CS; Choi HG
    Int J Pharm; 2007 Oct; 343(1-2):228-37. PubMed ID: 17597315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solubility and dissolution rate of ibuprofen in ionic and non-ionic micellar systems.
    Kokot Z; Zmidzińska H
    Acta Pol Pharm; 2001; 58(2):117-20. PubMed ID: 11501788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Non-solvent shock agglomeration"--the technology of a new alternative method for determination of ibuprofen. 6. Stability of s(+)-ibuprofen].
    Möller T; Korsatko W
    Pharmazie; 2000 Jun; 55(6):449-53. PubMed ID: 10907254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution enhancement by bio-inspired mesocrystals: the study of racemic (R,S)-(+/-)-sodium ibuprofen dihydrate.
    Lee T; Zhang CW
    Pharm Res; 2008 Jul; 25(7):1563-71. PubMed ID: 18302008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commercially viable resolution of ibuprofen.
    Chávez-Flores D; Salvador JM
    Biotechnol J; 2009 Aug; 4(8):1222-4. PubMed ID: 19455529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thermodynamic properties of flufenamic and niflumic acids--specific and non-specific interactions in solution and in crystal lattices, mechanism of solvation, partitioning and distribution.
    Perlovich GL; Surov AO; Bauer-Brandl A
    J Pharm Biomed Anal; 2007 Nov; 45(4):679-87. PubMed ID: 17336023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADIDAC trial: analgesia with dexibuprofen versus ibuprofen in patients suffering from primary dysmenorrhea: a crossover trial.
    Kollenz C; Phleps W; Kaehler ST
    Gynecol Obstet Invest; 2009; 67(1):25-31. PubMed ID: 18824862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.